Three of the Biggest Financings Set No Price At All
A withdrawal ends a registration rather than pausing one, and the private capital replacing it leaves no reference price behind for the holders who will need one.
What a withdrawal actually does
Motive filed for an NYSE listing on December 23, 2025, delayed in January, and on Thursday filed a Form RW. The mechanical difference is the whole story: a delay leaves the registration statement on file, while a withdrawal ends the process and requires an entirely new filing to restart. There is no revised timetable, no disclosed valuation, and no priced reference. In its place came more than $1.3 billion from General Catalyst's Customer Value Fund at an undisclosed price, with Pranav Singhvi joining the board and CEO Shoaib Makani framing it as staying private while continuing to invest.
This is not a rescue. Motive carries roughly $600 million of ARR growing 30% year over year, with revenue from six-figure customers up nearly 60%, per Paul Smalera's reporting. A company with that profile chose structured private capital over a public price, which tells you what the sponsor thinks a public price would have been.
Zero reference prices, three deals
Motive was not alone. Stoke Space announced a first close on a $1 billion Series E with valuation undisclosed, taking total funding to $2.3 billion. Cylake raised a $245 million convertible note six months after a $45 million Greylock seed, while still pre-beta. That is nine figures of capital, three times over, with no equity reference attached.
The mechanism that produced this cycle's ugliest software resets was never business deterioration. It was deferred price discovery: companies grew, never took another priced round, and carried a peak mark as the official reference until a transaction forcibly replaced it. Every one of these unpriced financings recreates that condition for a new cohort of holders.
Why the timing is different from six months ago
The 10-year Treasury closed at 4.944%, up 11 basis points, per Morning Brew, and wholesale inflation printed in line while investors sold anyway. Fed-funds futures price roughly a 70% chance of a quarter-point increase at the September 15-16 meeting. Not a cut. Late-stage private marks respond to discount rates with a lag, which means the repricing pressure now arriving has not yet passed through the book.
The divergence between the two markets is measurable in the same period. Boring Co. raised at a $23 billion valuation while the Nasdaq closed lower for a fourth consecutive session. And where a public price does exist, it is unsentimental: SpaceX closed at $147.55, down 3.86%, only about 9% above its $135 IPO price, with 328.4 million shares unlocking September 24, further tranches on October 9 and 24, and up to 1.3 billion tied to Q3 results.
Where the sources disagree
a16z reads the two-speed market as asset-class strength: trophies trade at premiums to last round, and actively-raising unicorns compressed median time between rounds to 1.0 year in Q1 2026 from 1.5 years in 2024 (Mach Industries went $1.8B to $3.7B in three months; Ramp is in talks at roughly $60B against a $44B Series F). The private-markets reporting reads the same distribution as deferral, noting that 51.2% of companies that once cleared unicorn status have not raised in over two years. Both descriptions are accurate. Only one of them describes the half of the market where most fund NAV actually sits.
A withdrawn registration is not a slower IPO. It removes the only mechanism that would have printed a price.
The practical consequence is that headline equity value and common recovery have decoupled, and structured growth capital sits between them. Waterfall first, mark second.
What to do
Re-run every top-ten position and live deal model at a 5.0% risk-free rate this week and publish the NAV sensitivity in the Q3 LP letter before quarter-end.
Commission a liquidation-preference waterfall on every position whose last reference price came from an undisclosed or structured financing, starting with Customer Value Fund-style growth deals, by quarter-end.
Require a written price-discovery milestone in every new structured or convertible term sheet you sign from this quarter forward.